Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Cash from Operations (2017 - 2021)

Cogent Biosciences has reported Cash from Operations over the past 5 years, most recently at 20777000.0 for Q4 2021.

  • Quarterly results put Cash from Operations at 20777000.0 for Q4 2021, down 121.83% from a year ago — trailing twelve months through Dec 2021 was 58763000.0 (down 63.91% YoY), and the annual figure for FY2025 was 264444000.0, down 27.26%.
  • Cash from Operations for Q4 2021 was 20777000.0 at Cogent Biosciences, down from 14109000.0 in the prior quarter.
  • Over the last five years, Cash from Operations for COGT hit a ceiling of 5761000.0 in Q2 2017 and a floor of 20777000.0 in Q4 2021.
  • Median Cash from Operations over the past 5 years was 8732500.0 (2018), compared with a mean of 9722550.0.
  • Biggest five-year swings in Cash from Operations: soared 31.47% in 2020 and later crashed 121.83% in 2021.
  • Cogent Biosciences' Cash from Operations stood at 6516000.0 in 2017, then plummeted by 38.43% to 9020000.0 in 2018, then rose by 6.37% to 8445000.0 in 2019, then fell by 10.91% to 9366000.0 in 2020, then crashed by 121.83% to 20777000.0 in 2021.
  • The last three reported values for Cash from Operations were 20777000.0 (Q4 2021), 14109000.0 (Q3 2021), and 12511000.0 (Q2 2021) per Business Quant data.